Zhang Y et al. reported PEGylated liposomes could deliver interleukin (IL)-2 and anti-CD137 (cluster of differentiation) mAb to the tumor and effectively delay tumor growth [30]. The gene discussed is TNFRSF9; the disease is neoplasm.